
Leonardo Calzetti
Founder of BluPhytal, a company which, trough its Rare Insight Consulting division, supports healthcare companies to develop their presence in the Orphan Disease arena.
Co-founder of BlueDil International, wich serves as virtual affiliate for Pharma Companies in Europe, providing a cost-effective approach establishing and expanding business in the market of rare disease orphan drugs across Europe and beyond.
From 2016 to 2019 Leonardo has served as Head of Global Rare Diseases Franchise at Chiesi, managing the Strategic Marketing process and supporting Business Development activities.
From 2008 to 2015 Leonardo has created and developed the Italian affiliate of Swedish Orphan Biovitrum (SOBI), managing also Greece and Malta territories. In this role Leonardo has represented SOBI into Assobiotec (Italian Association for the Development of Biotechnologies) becoming member of the directive board.
Previously has spent 20 years in pharma business in positions with increasing responsibility in operational and strategic marketing, mainly in rare or severe diseases.